DRW Securities’s iRadimed IRMD Stock Holding History

DRW Securities’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,745	Closed	-$457K	–	1212
2026 Q1	$457K	Buy	+4,745	New	+$475K	0.01%	655

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DRW Securities's IRMD Position: Q2 2026 in Review

DRW Securities sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 4,745 shares — an estimated $457K sold.

DRW Securities first reported a position in IRMD in Q1 2026 and held it in 1 quarter. The position peaked at $457K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

DRW Securities reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 4,745 iRadimed shares in Q2 2026, an estimated $457K.
DRW Securities first reported a position in iRadimed in Q1 2026 and held it in 1 quarter.
DRW Securities's iRadimed position peaked at $457K in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.